NEW YORK, July 20, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ImmunityBio investors who were…